On the other hand, the lack of significant differences in blood NFL levels between FTD and ODs in stratum B studies can be mainly attributed to the investigation of Matías‐Guiu et al., where the median plasma NFL value of patients with AD was non‐significantly higher than that of patients with FTD [37]. The gene discussed is NEFL; the disease is Alzheimer disease.